Table 1.
Overactivation of the survival switch may drive metabolic diseases.
survival feature | disease | initial reversible mechanism | chronic less-reversible mechanism | references |
---|---|---|---|---|
weight gain and fat accumulation | visceral obesity | leptin resistance, ↑intestinal absorptive area, mitochondrial oxidative stress, lipogenesis, impaired fat oxidation | adipocyte senescence and mitochondria loss may lead to persistent obese state | [38,41,47,72,78,175] |
systemic insulin resistance and islet dysfunction | type 2 diabetes | systemic insulin resistance and impaired insulin secretion | loss of islets from oxidative injury and scarring leads to persistent diabetic state | [132] |
elevation of blood pressure | primary hypertension | uric acid-induced hypertension due to endothelial dysfunction, oxidative stress and angiotensin II | kidney-dependent hypertension associated with inflammation and salt-sensitivity | [176,177] |
fat deposition in liver | nonalcoholic fatty liver disease | fat deposition with mild inflammation | cirrhosis | [25,178] |
increase in lipids in blood | dyslipidaemia | increased risk for fat deposition in blood vessels | atherosclerosis | [179] |
preservation of kidney excretion | chronic kidney disease | uric acid-dependent hyperfiltration and elevated glomerular filtration pressure | progressive nephron loss from arteriolopathy, inflammation and hyperfiltration | [91,92,180] |
elevations in uric acid (part of general survival response) | gout, CKD and heart disease | gout and urate crystal deposition in blood vessels and kidney, systemic inflammation | crystal deposition leads to local injury and scarring, atherosclerotic plaques, vascular calcification | [181,182] |
protect from hypoxia (mitochondrial suppression with stimulation of glycolysis) | obesity-associated cancers | stimulate cancer growth by allowing cells to better survive in hypoxic environments before blood supply is established | cancer metastases (especially breast, colon, pancreatic) | [111] |
activated at sites of tissue ischaemia (kidney, heart) | local oxidative stress and inflammation exacerbate local tissue injury | cardiac remodelling, kidney tissue scarring | [16,183] | |
foraging behaviour | behavioural disorders (ADHD, bipolar disease, gambling), Alzheimer's disease | decreased cerebral glucose metabolism in insulin-dependent areas associated with self-control, deliberation and recent memory | mitochondrial loss, neuronal loss | [74,75,88] |
recurrent activation of the switch | accelerated ageing | low grade inflammation, mitochondrial suppression, decreased Nrf2, sirtuins | mitochondria loss, capillary loss, low grade scarring | [145] |
pregnancy | preeclampsia | ischaemia drives continued fructose generation in placenta and fetus | increased long-term risk for hypertension and kidney disease | [18] |
chronic stimulation of ACTH via V1b receptor | aldosteronism | aldosterone breakthrough, aldosterone effects in resistant hypertension | development of primary aldosteronoma | [184] |